Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model. in . The tender was released on Apr 17, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.

Deadline - Mar 31, 2026

MT reference number - 81003133

Product classification - Office and computing machinery, equipment and supplies except furniture and software packages

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 81003133

  Document Type - Tender Notices

Login

Notice Details and Documents:

Description - Description: Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Lamivudin, Tenofovirdisoproxil und Doravirin (J05AR24) im Rahmen eines sogenannten Open-House-Modells.

Mt Ref Id - 81003133

Deadline - Mar 31, 2026

Login

Share

View more tenders for

Office and computing machinery Tenders Germany Tenders

Similar Tenders :

Most Searched